IMR Press / FBL / Volume 27 / Issue 6 / DOI: 10.31083/j.fbl2706187
Open Access Original Research
A Method of Generating a Classifier that Determines the Presence or Absence of IBS Symptoms by Supervised Learning from the Frequency Analysis of Electroencephalogram Data
Show Less
1 Department of Rehabilitation, Graduate School of Health Sciences, Saitama Prefectural University, Koshigaya, 343-8540 Saitama, Japan
2 Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8575 Miyagi, Japan
3 Faculty of Human Sciences, Waseda University, Mikajima, Tokorozawa City, 359-1192 Saitama, Japan
*Correspondence: hamaguchi-toyohiro@spu.ac.jp (Toyohiro Hamaguchi)
Academic Editor: Sébastien Kindt
Front. Biosci. (Landmark Ed) 2022, 27(6), 187; https://doi.org/10.31083/j.fbl2706187
Submitted: 8 March 2022 | Revised: 31 March 2022 | Accepted: 19 May 2022 | Published: 9 June 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Young adults with irritable bowel syndrome (IBS) occasionally exhibit specific abdominal symptoms, including abdominal pain associated with brain activity patterns. Decoded neural feedback (DecNef) is a biofeedback exercise that allows symptomatic people to exercise self-control over their brain activity patterns relative to those without symptoms. Thus, DecNef can be used to self-control abdominal pain in patients with IBS. To establish a DecNef practice for IBS, it is necessary to develop a classifier that can distinguish the electroencephalography (EEG) patterns (EEG signatures) of IBS between symptomatic and healthy people. Additionally, the accuracy of the “classifier” must be evaluated. Methods: This study analyzed EEG data obtained from symptomatic and asymptomatic young adults with IBS to develop a support vector machine-based IBS classifier and verify its usefulness. EEG data were recorded for 28 university students with IBS and 24 without IBS. EEG data were frequency-analyzed by fast Fourier transform analysis, and IBS classifiers were created by supervised learning using a support vector machine. Results: The diagnostic accuracy of IBS symptoms was verified for the whole brain and the frontal, parietal, and occipital regions. We estimated >90% accuracy of the IBS classifier in the whole brain and frontal region. Conclusions: The results of this study suggest that EEG data can be used to determine the presence or absence of IBS symptoms. With the IBS classifier, EEG may help provide feedback regarding the presence or absence of symptoms to patients, which is the basis for developing self-management strategies for IBS.

Keywords
irritable bowel syndrome
electroencephalogram
support vector machine
supervised learning
self-management
1. Introduction

Irritable bowel syndrome (IBS) is a disorder associated with the dysfunction of the brain–gut interaction, characterized by chronic recurrent abdominal pain and altered bowel movements [1, 2, 3]. In addition, IBS patients frequently present with symptoms associated with anxiety, depression, and somatization [4]. These symptoms affect the quality of life (QOL) of IBS patients [5], and the severity of abdominal symptoms in IBS is a predictor of reduced QOL in relation to physical health [6]. The symptom severity can be evaluated according to the IBS subtype Rome IV criteria to understand the pathophysiological mechanisms accurately [7]. The prevalence of IBS is estimated to be 4.1% of the worldwide population, according to a large multinational study [8], and IBS is particularly common in young adult women with low body mass index in Japan [9, 10]. However, obesity and IBS are positively correlated, as observed in Western populations, resulting in regional differences in prevalence [11]. As a treatment strategy for IBS, maintaining the rhythm of life and improving lifestyle can help reduce mild IBS symptoms [12]. Lifestyle and dietary advice (low FODMAP: Fermentable Oligo-, Di-, Mono-saccharides, And Polyols) is offered as an option for IBS symptom relief, especially in the initial management [13]. However, frequent and prolonged abdominal pain often interferes with daily activities, like commuting to school or work, among patients with IBS, even in mild cases. Relieving abdominal pain poses a challenge in rehabilitation efforts to improve the patients’ quality of life, and guidelines for the treatment of IBS recommend pharmacotherapy for frequent diarrhea or constipation [14, 15]. For moderate-to-severe IBS, drugs that modulate central neurotransmission—such as those that raise visceral sensory thresholds—have certain advantages, especially antidepressants [16]. If a patient does not respond to these medications, psychosomatic treatments such as cognitive-behavioral therapy, hypnotherapy, and autogenic training have also been shown to be effective [17, 18]. Therefore, the development of a self-care strategy that raises the visceral perception threshold for IBS can be an important form of non-pharmacological rehabilitation for such patients.

Abdominal pain (the main symptom of IBS) is subjective because the signals from the abdomen undergo processing in the brain [19]. Event-related potentials in the right parietal lobe region of the brain are normalized by attention bias modification in IBS patients [20]. Moreover, brain research suggests that gastrointestinal hypersensitivity is a diagnostic marker of IBS [21]. When not performing a specific function, human brain functions form a distinctive default mode network (DMN) or resting state functional connectivity (RSFC) [22]. A study on the DMN used a method to identify the activity patterns and brain regions that can discriminate between diseased and healthy groups [23]. When using an analytical method based on machine learning, the brain activity of the disease group or participant is matched to the brain activity pattern (EEG signature) to predict the patient’s condition [24]. In a previous study, we validated the DMN of the brain–gut correlation by investigating functional brain imaging data collected during a gastrointestinal stretch stimulation [25]. The results showed weak functional connectivity between the dorsolateral and medial prefrontal cortices in the DMN of symptomatic patients with IBS, suggesting that they are sensitive to gastrointestinal perception. Among the brain regions that form the DMN, the posterior cingulate cortex is particularly involved in “preoccupation with one’s self” [26]. However, humans often experience thoughts unrelated to a given task, and this phenomenon is now being examined for its positive medical applications [27, 28]. In other words, it is hypothesized that IBS symptoms will decrease if the DMN in IBS patients can be induced to the same patterns as in people without abdominal pain.

Similar biofeedback techniques have been used for stress management, rehabilitation of motor paralysis, relaxation, and mental training in sports [29, 30, 31, 32]. Among the various biofeedback methods, the neurofeedback technique is used as an index for regulating brain activity in a method known as decoded neural feedback (DecNef). This is a method of training the brain network to discriminate the differences between the pathological state of brain activity at rest or during a task and to adjust the activity of relevant brain regions through self-control mechanisms [33]. In DecNef, biological information (such as EEG and brain images) is first presented to subjects in the form of easily recognizable representations such as sound, light, and images. Subsequently, the participant adjusts their biological responses based on this information. Establishing DecNef in practice requires a classifier that can discriminate the different biological signals between IBS patients and healthy subjects and a display device that provides feedback to the treatment participant regarding decoded brain information [34]. The IBS classifier is a tool used to predict the degree of abdominal pain in symptomatic patients and judge the effect of therapeutic intervention. Current classifiers use functional magnetic resonance imaging (fMRI) to obtain detailed functional brain images [35, 36]. However, it may be possible to develop a classifier that discriminates between symptomatic and asymptomatic patients with IBS by analyzing real-time changes in the frequency and amplitude of the electroencephalogram (EEG). This may help predict the degree of abdominal pain in symptomatic patients and evaluate the effect of therapeutic intervention. Moreover, if an EEG classifier is developed for IBS, DecNef methods may be developed for the self-regulation of abdominal pain in patients with IBS.

Brain research using machine learning is based on output data from the examination of brain activity, and researchers have estimated the presence or absence of a phenomenon using such brain activation data [37]. Using this method, IBS patients are classified not only on the basis of abdominal pain, but also on whether their specific brain activity corresponds to that of the disease group [38, 39]. Therefore, it is possible to diagnose diseases, track the course of treatment, and evaluate interventions using brain activity data. In machine learning algorithms, the brain activity associated with a characteristic phenomenon (for example, abdominal pain) is detected and examined (for example, using principal component analysis) to create a classifier that can discriminate between diseased and healthy groups. In IBS patients, we can evaluate the accuracy of discriminating DMN patterns characteristic of IBS by matching the brain activities of healthy people to a classifier. Because the DMN is closely associated with the recognition process of visceral perception, this function can create a new objective scale for evaluating abdominal pain and verifying the feasibility of DecNef. Therefore, the purpose of this study was to verify the usefulness of a classifier as a basis for the development of DecNef by analyzing EEG data obtained from symptomatic and asymptomatic patients with IBS.

2. Materials and Methods
2.1 Study Design

In this study, we used a cross-sectional study design, created a classifier to discriminate EEG features between symptomatic and asymptomatic patients with IBS, and verified the rate of positive diagnoses of IBS in symptomatic patients using EEG data.

2.2 Participants and Recruitment

The eligibility criteria for study participants were as follows: (1) university students aged 18 years; and (2) right-handed individuals with a score of at least 70 points on the Edinburgh Handedness Inventory (EHI). The exclusion criteria were the presence of psychiatric disorders and functional gastrointestinal diseases other than IBS.

University students were recruited between March 2013 and September 2020 for the verification of EEG-based discrimination of IBS symptoms. For the recruitment of participants, an e-mail containing the outline of the experiment was prepared and sent to university students after approval by the Ethics Committee. The research procedure was explained to the participants who met the eligibility criteria, and all participants consented to participate in this study.

2.3 Samples for Analysis

Participants who met the eligibility criteria during the study period were included. Prior to the study, verbal and written explanations were provided to the participants, and those who provided written consent were asked to participate in the experiment. Based on previous studies comparing EEG results in symptomatic and asymptomatic patients with IBS, we determined a sample size of 11 participants in each group. Based on estimated data loss, the group size was set to 30. To investigate whether the EEG data can discriminate the presence of IBS, 15 participants were randomly selected using a random number table and included in the first analysis (derivation study) according to their symptoms. After fitting the data to a machine learning algorithm, a second analysis (validation study) was conducted to investigate whether this classifier could discriminate the EEG data of IBS patients. The remaining participants were included in this validation study. The data obtained were analyzed by a statistician blinded to the presence or absence of IBS symptoms, in a single-blind study design.

2.4 Research Ethics

This study was approved by the Review Boards of Saitama Prefectural University (#24075) and Nagasaki University (#13072632). The principal investigator met with the students who met the eligibility criteria, explained the purpose and method of the study, and obtained informed consent. The students were informed of their right to withdraw from the study at any time. At the time of enrollment, the students provided written consent for the collection and use of their key characteristics and basic data.

2.5 Experimental Protocols

Among students who met the eligibility criteria, the presence or absence of IBS symptoms was determined using a questionnaire based on the Rome IV criteria [40]. Students with IBS symptoms were defined as the IBS group, and those without IBS symptoms were defined as the non-IBS group. In the experiment, we first administered a questionnaire to the participants regarding IBS symptoms. Next, the participants were placed in a supine position with their eyes closed for 5 min, and then underwent EEG measurements for 10 min (Fig. 1).

Fig. 1.

Schematic representing the electroencephalogram (EEG) analysis and tests for the predictive accuracy of the irritable bowel syndrome (IBS) classifier. (A) A flowchart of the study protocol from the recruitment of participants to EEG data analysis. Participants assessed for the presence of IBS symptoms are subjected to EEG examination, and the target frequency bands (α and β bands) of the EEG data are extracted by fast Fourier transformation. (B) A support vector machine (SVM) is used to create a classifier that can discriminate the EEG patterns of participants with and without IBS symptoms using machine learning and the α and β bands of the frequency-analyzed EEG data. (C) Validation of the discrimination accuracy of the classifier for IBS symptoms. EEG test data are discriminated by the classifier, and the discrimination accuracy between patients with and without IBS is calculated.

2.6 Experimental Procedure

After recording the height, weight, and body mass index of consenting participants, we administered the EHI—a 10-item questionnaire in which the participants answered questions regarding their use of the left and right hands. A positive value indicated right-handedness, whereas a negative value indicated left-handedness. The Rome IV self-administered questionnaire was also administered, in which participants answered questions regarding the intensity and frequency of abdominal symptoms.

2.7 EEG Measurement

EEG was recorded using Ag/AgCl electrodes at 11 sites (F3, F4, C3, C4, P3, P4, O1, O2, Cz, Fz, and Pz) in accordance with the international 10–20 method. A reference electrode was placed on the right earlobe. During EEG acquisition, the sampling time was 1 ms, and the impedance between the electrode and scalp was adjusted to less than 50 Ω for accurate acquisition. The EEG was recorded using a Polymate Pro MP6100 system (Miyuki Giken. Co., Ltd., Tokyo, Japan). Participants remained conscious, but were instructed to keep their eyes closed at rest during the measurements to control for biological artifacts. EEG was monitored throughout the measurement period to ensure that the participants were awake. The experimenter provided appropriate warnings to the participants when necessary.

2.8 Quantification of EEG Analysis

EEG data were visually examined to confirm the absence of biological artifacts and sudden EEG abnormalities, and then analyzed using the EMSE application (EMSE Suite; Source Signal Imaging, San Diego, CA, USA) implemented on a computer. EEG data were filtered in the frequency range of 0.5–30 Hz using the right earlobe as a reference, and the data were analyzed using fast Fourier transform (FFT) processing and time-frequency analysis. The time window for frequency analysis was set to 10 s, and the overlap was set to 50%. The total power was obtained by adding the powers 8.0 of 29.8 Hz. The total potency was expressed as a percentage of the total power for each participant, and α (8.0–12.8 Hz) and β (13.0–29.8 Hz) bands were extracted. FFT is a method for transforming time-series data into the frequency domain, and it can capture the frequency changes that cannot be supplemented by time-series data. Due to its fast processing time, it is also excellent for generating control signals for robots. The raw EEG data and samples by band are shown in Fig. 2.

Fig. 2.

Examples of electroencephalogram (EEG) patterns in patients with irritable bowel syndrome (IBS). (A) Elapsed time (x-axis) and actual waveform of each channel (y-axis) in the EEG measurements. Data were recorded for 10 minutes, and those in the time window of 120–240 s (shown in gray shading) were analyzed. (B) EEG waveforms of IBS patients processed using the power spectra. The α (8.0–12.8 Hz) and β (13.0–29.8 Hz) bands highlighted in gray shading were analyzed.

2.9 EEG Analysis

The EEG data of participants whose α waves were outliers in any channel were excluded using the Smirnov-Grubbs test. We excluded data with values above the thresholds of 2.714 for IBS subjects and 2.773 for non-IBS, calculated using α power percentages from EEG data. This method has been used in neurofeedback studies and can reduce the effects of excessive noise [41]. EEG data in the time window of 120–240 s were analyzed, and frequency analysis was performed using EMSE to extract data in the α- and β-wave bands. The channels located anterior to the central sulcus (F3, F4, C3, C4, Fz, and Cz) were considered to be the frontal region The C3, C4, P3, P4, Cz, and Pz) channels ranged from the central sulcus to the dorsal region, and the channels P3, P4, O1, O2, and Pz ranging from the parieto-occipital sulcus to the dorsal side were considered to be the occipital region. EEG data for each group were tested for normality using the Shapiro–Wilk test and amplified to 1000 data points (total, 2000 data points) using the parametric bootstrap method.

2.10 Creation of a Support Vector Machine Classifier and Evaluation of its Discriminative Ability
2.10.1 Support Vector Machines

Support vector machines (SVMs) are supervised machine-learning methods used for classification and regression [42]. A linearly separable sample set is denoted as (xi,yi),i=,,n,xRd, including y+1,-1 class labels. The general formula for the linear discriminant function (Eqn. 1) is as follows:

(1) g ( x ) = ω x + b

The SVM algorithm finds an optimal separating hyperplane that can classify samples without errors and maximize the distance between any class and the separating hyperplane. To classify all the samples correctly, the following conditions must be satisfied:

(2) y i [ ( ω x i ) + b ] - 1 0 , i = 1 , 2 , , n

The margin between the two classes being classified is (2/ω). From this point of view, maximizing the margin is equivalent to minimizing it to ω2/2.

We can optimize the solution of the problem using Eqn. 2, as given by the saddle point of the Lagrangian function. The optimal discriminant function is as follows:

(3) f ( x ) = sgn { ( ω * x ) + b * } = sgn { α i * i = 1 n y i ( x i x ) + b * }

The extended optimal separating hyperplane is determined by replacing Eqn. 3 using the kernel function K(x,x). Therefore, the original feature space is mapped to a new higher-dimensional space, where the linear separability of the projected samples is enhanced. Therefore, the discriminant function (Eqn. 4) changes as follows:

(4) f ( x ) = sgn { α i * i = 1 n y i K ( x i , x ) + b * }

The SVM is adaptable to cases where linear separation is possible or impossible. This has been extended to construct nonlinear discriminant functions using kernel tricks. In this study, we used the Gaussian kernel in Eqn. 5 as follows:

(5) k ( x i , x ) j = exp ( i - γ x - x j 2 )

2.10.2 Creating an SVM Classifier

The data of the α- and β-wave bands were amplified using the bootstrap method; 90% of the data were used as training data for supervised machine learning, and the remaining 10% were used as test data to evaluate the discriminative ability of the classifier. We created classifiers using the ksvm function in the “kernlab” package in R statistical software (R Core Team. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/, 2019.).

2.10.3 Evaluation of the Discriminative Ability of the Classifier

The discriminative power of the classifier was evaluated using a bootstrapped dataset. Classification was quantified using a confusion matrix. According to Han et al. [43], a confusion matrix tool can be used to apply classifier analysis to recognize various classes. In this study, we examined whether the SVM classification model established in the training dataset could discriminate the EEG of the test datasets between participants with and without IBS. This validation procedure was repeated 10 times, and the accuracy rate was calculated as AR = (TP + TN)/N (AR, accuracy rate; TP, true positive; TN, true negative; N, sum of true positive, true negative, false positive, and false negative). The calculation method for the positivity rate is detailed in Table 1.

Table 1.Method of estimating the accuracy rate of the support vector machine classifier.
IBS Non-IBS Equation
IBS positive True positive: a False positive: b Sensitivity
= a / (a + b)
IBS negative False negative: c True negative: d Specificity
= d / (c + d)
Total IBS symptoms Precision Negative predictive value Accuracy rate
= a / (a + c) = d / (b + d) = (a + d) / (a + b + c + d)
IBS, irritable bowel syndrome.
True positive indicates a correctly labeled positive. True negative indicates a correctly labeled negative record.
2.11 Statistical Analysis

In the statistical analysis, the EEG data obtained from each group were tested for normality using the Shapiro-Wilk test. After confirming normality, the band-specific data for each channel amplified by the bootstrap method were tested for associations with IBS symptoms using a multivariate analysis of variance. Post-hoc analyses with unpaired t-tests were performed to compare each channel for each IBS symptom. The SVM classifier was used to calculate the rate of positive diagnoses, sensitivity, and specificity of the IBS symptoms. Demographic data were compared using the chi-square and Mann–Whitney U tests. All statistical tests were performed in R using R Studio (version 1.1.4; R Foundation, Boston, USA), with the significance level set at 5%.

3. Results
3.1 Enrollment and Student Characteristics

A consent form for participating in the study was sent via email, and 60 students who met the eligibility criteria were enrolled in this study (mean age = 20 ± 1 years). Those with an EHI of 80% were considered right-handed [44, 45]. Right-handed participants were evaluated for the presence of IBS symptoms based on the Rome IV criteria and divided into two groups: 32 participants with IBS symptoms (IBS group) and 28 without IBS symptoms (non-IBS group) (Fig. 3). The IBS QOL was recorded for each participant prior to EEG measurement. The data of eight participants were excluded from analysis because they exceeded the group mean + standard deviation in at least one of the channels). In total, the EEG data of 52 participants were analyzed. The groups based on IBS symptoms were as follows: IBS with predominant constipation (IBS-C, n = 9), predominant diarrhea (IBS-D, n = 6), mixed bowel habits (IBS-M, n = 7), and unclassified (IBS-U, n = 6) [40]. In addition, the training dataset for machine learning included four IBS-C, five IBS-D, four IBS-M, and two IBS-U subjects, and the validation dataset included five IBS-C, one IBS-D, three IBS-M, and four IBS-U subjects. The scores of IBS QOL were similar between groups (Table 2).

Fig. 3.

Selection process of the study population and study design. Among the participants screened for IBS symptoms, 60 students selected by random sampling were enrolled in this study. Then, EEG measurements and psychological tests were performed, and participants with outliers in EEG data were excluded. The participants finally included in the analysis were 28 in the IBS group (training: 15, validation: 13) and 24 in the non-IBS group (training: 15, validation: 9).

Table 2.Characteristics of subjects in relation to IBS subtype and domains of quality of life.
Variables IBS group (n = 28) Non-IBS group (n = 24) Statistics
Male female male female
Participants (n) 6 22 8 16 n.s.
Age (mean years) 19 20 19 19 n.s.
IBS subtypes (n)
IBS-C 2 7 n/a n/a n.s.
IBS-D 0 6 n/a n/a n.s.
IBS-M 2 5 n/a n/a n.s.
IBS-U 2 4 n/a n/a n.s.
IBS quality of life
Dysphoria 74.0 ± 39.2 74.9 ± 16.8 90.2 ± 16.7 77.3 ± 20.7 1p = 0.25
2d = 0.32
Interference with activity 75.6 ± 33.5 76.0 ± 19.2 91.5 ± 14.5 77.9 ± 19.7 1p = 0.26
2d = 0.31
Body image 87.5 ± 19.0 79.6 ± 16.3 94.5 ± 10.3 78.5 ± 17.8 1p = 0.59
2d = 0.15
Health worry 86.1 ± 26.7 77.3 ± 16.1 88.5 ± 14.0 83.3 ± 18.8 1p = 0.24
2d = 0.33
Food avoidance 80.6 ± 36.0 67.8 ± 28.6 88.5 ± 18.3 70.3 ± 25.1 1p = 0.45
2d = 0.21
Social reaction 84.4 ± 35.3 88.6 ± 9.9 97.7 ± 4.65 90.2 ± 10.7 1p = 0.22
2d = 0.34
Sexual concerns 89.6 ± 25.5 91.5 ± 14.6 100.0 ± 0.0 96.1 ± 9.9 1p = 0.10
2d = 0.46
Relationships 81.9 ± 36.7 82.6 ± 12.0 89.6 ± 13.2 83.9 ± 22.9 1p = 0.54
2d = 0.17
For statistical analysis, we used the t-test corresponding to the IBS quality of life after the normality test. 1Test between two groups according to differences in IBS symptoms. 2Effect size in each test. n/a, not applicable; n.s., not significant; IBS-C, IBS with predominant constipation; IBS-D, predominant diarrhea; IBS-M, mixed bowel habits; IBS-U, unclassified.
3.2 Comparisons of EEG Bands and α and β Power Percentages in Groups with and without IBS Symptoms

The MANOVA results including α and β wave channels according to IBS symptoms were df (1, 50), Pillai: 0.658, p = 0.01. Post-hoc analyses revealed significant differences between groups in α and β power percentages in EEG channels. Intergroup differences were found in α power percentages in the F3 (t = –3.54, p < 0.001, r = 0.08), C3 (t = 2.77, p = 0.006, r = 0.06), Cz (t = –2.24, p = 0.025, r = 0.05), P3 (t = 4.31, p < 0.001, r = 0.10), Pz (t = 3.87, p < 0.001, r = 0.09), P4 (t = 4.53, p < 0.001, r = 0.10), O1 (t = –3.63, p < 0.001, r = 0.08), and O2 (t = –3.63, p < 0.001, r = 0.08) channels. Significantly differences in β power percentage were found in all channels as follows: F3 (t = 7.21, p < 0.001, r = 0.16), Fz (t = 6.15, p < 0.001, r = 0.14), F4 (t = 9.10, p < 0.001, r = 0.20), C3 (t = 10.40, p < 0.05, r = 0.23), Cz (t = 8.52, p < 0.001, r = 0.19), C4 (t = 10.21, p < 0.001, r = 0.22), P3 (t = 11.06, p < 0.001, r = 0.24), Pz (t = 10.86, p < 0.001, r = 0.24), P4 (t = 13.88, p < 0.001, r = 0.30), O1 (t = 8.47, p < 0.001, r = 0.19), O2 (t = 10.47, p < 0.001, r = 0.23) (Fig. 4).

Fig. 4.

Comparison of power percentages of EEG bands in participants with and without IBS symptoms. The EEG data are shown according to the frequency band in each channel, and the power percentages are compared. Error bars indicate the standard error of the mean. *p < 0.05.

3.3 Discriminative Ability of the SVM Classifier to Differentiate EEG Data by IBS Symptoms

The EEG data in the α- and β-bands collected from randomly selected participants with (n = 15, subtypes: four IBS-C, five IBS-D, four IBS-M, and two IBS-U) and without (n = 15) IBS were bootstrapped to 1000 iterations per channel. In the amplified data, 1500 of the 2000 samples were defined as a supervised training dataset for the SVM to generate IBS classifiers. The remaining 500 samples were used to test whether these classifiers could automatically distinguish between the EEGs of IBS and non-IBS groups. Subsequently, to test whether the generated classifiers could discriminate EEGs based on IBS symptoms, bootstrapped data from participants with (n = 13, subtypes: five IBS-C, one IBS-D, three IBS-M, and four IBS-U) and without (n = 9) IBS were newly included, and the discriminative ability of classifiers was tested in each brain region (Fig. 5). Table 3 lists the accuracy, sensitivity, specificity, and rates of positive predictions (for symptomatic and asymptomatic participants) of the SVM classifier based on 10 repeated measurements. In the frontal region, the SVM classifier showed high discrimination accuracy and low variability in the rate of positive diagnosis of the IBS (0.860–0.949; mean, 0.908; 95% confidence interval, 0.890–0.926) and non-IBS (0.840–0.947; mean, 0.898; 95% confidence interval, 0.8–076.921) groups (Fig. 6).

Fig. 5.

Three-dimensional discrimination map of electroencephalography (EEG) data according to the generated classifier. The α and β bands of each measurement region are shown, as calculated by analyzing the EEG data. The x- and y-axes indicate the power percentages in the α and β bands, respectively, and the numbers indicate the number of plots for each frequency band (z-values). A higher z-axis area indicates the irritable bowel syndrome (IBS) group, and a lower z-axis area indicates the non-IBS group (that is, the cut-off point for discriminating the presence of IBS symptoms). For example, in F3, patients with IBS have a lower α power percentage and a higher β power percentage.

Fig. 6.

Evaluation of the discriminative ability of the support vector machine classifier for each brain region. The model diagram shows the discrimination accuracy of the classifier in the electroencephalography channels in the frontal, parietal, and occipital regions. A 3D discrimination map for each brain region (top) and accuracy rates (bottom) are shown. The graphs show the number of discrimination trials (x-axis) and the accuracy rate (y-axis), and the accuracy rate of the whole brain is shown as a reference. Gray and orange error bars indicate the 95% confidence interval of each data point.

Table 3.Accuracy rates of support vector machine classifications.
Measure Whole brain Frontal region Parietal region Occipital region
Mean SD Mean SD Mean SD Mean SD
Accuracy rate 91.75 1.44 90.35 2.29 84.40 2.56 77.50 2.16
Sensitivity 90.99 3.40 89.94 3.22 81.79 3.85 66.34 2.94
Specificity 92.56 3.01 90.88 2.47 87.30 2.36 89.98 3.30
Positive prediction 92.23 3.17 90.84 2.91 86.87 3.01 88.17 3.60
Negative prediction 91.43 3.21 89.82 3.60 82.00 4.85 70.58 3.89
SD, standard deviation.
4. Discussion

In this study, we generated a classifier to determine the symptoms of IBS using the discriminant frequencies of the α and β bands from the EEG channels of symptomatic and asymptomatic participants with IBS. Using this classifier, we tested the rate of positive discrimination of EEG segments in young adults with IBS symptoms. The SVM classifier demonstrated high accuracy in discriminating IBS symptoms (whole brain: 90.0–94.5%; frontal region: 88.0–94.0%). Studies analyzing EEG power spectra have reported β-power enhancement and α-power attenuation in IBS [46, 47]. In previous studies, the accuracy rates of SVM classifiers for EEG data were reported to be 59.9–64.9 [38] and 67.2% [48]. Our results indicate that IBS symptoms can be discriminated using classifiers based on the α and β bands of EEG data of the whole brain or the frontal region. These findings suggest that bootstrap-based machine learning can more accurately determine the presence or absence of IBS symptoms when more α- and β-band data are recorded, thus enhancing the discrimination ability of the classifier. Although the SVM is one of the simplest mechanisms in artificial intelligence, its computational simplicity and quick discrimination make it suitable for implementation in the DefNec training system. In addition, the high accuracy of IBS discrimination by the SVM classifier using EEG data from the frontal region indicates that the acquisition of electric potential from this region is sufficient for discrimination, which allows the creation of a compact self-care training device.

Studies have reported the characteristics of the DMN when it is not performing a particular function in humans [49]. In IBS, excessive attention to body sensations (body vigilance) is accompanied by gastrointestinal hypersensitivity [50]. However, analysis of the characteristic DMN in this context is still in progress. Characteristic DMNs are possible to discriminate based on the characteristics of EEG spectra associated with biological responses and emotional recognition [51]. Studies using positron emission tomography (PET) and magnetic resonance imaging (MRI) have reported that brain functions are different between asymptomatic and symptomatic patients with IBS who have gastrointestinal hypersensitivity as a result of stimulation of the colon [52]. Ezra et al. [53] reported that the insular cortex and periaqueductal gray (PAG) area—which are important for perception—are connected in patients with IBS who are prone to chronic repetitive abdominal pain. In addition, chronic pain has been shown to occur in the dorsolateral prefrontal cortex and PAG [54] area. In patients with IBS, brain function in response to chronic abdominal pain tends to show dysregulation in the frontal-parietal region. Gastrointestinal hypersensitivity (one of the symptoms of IBS) can be reproduced by the repetitive mechanical stretching of an indwelling balloon in the intestine [55]. Constant repetitive brain-gut disturbances often induce abdominal pain and visceral hypersensitivity in IBS patients. A comparison of intestinal and brain activity after food intake between IBS patients and healthy participants revealed that the amount of ascending colon gas increased equally, while the activity in the brain region associated with intestinal pain was different [56]. Because the abnormalities in the brain–gut correlation in IBS are usually reflected in an EEG, we speculate that the SVM classifier developed here is highly accurate.

Classifiers generated by machine learning using PET and MRI data have been used as DecNef for psychiatric disorders, and their effectiveness has been verified [57, 58]. However, the device used for data acquisition using these techniques is too large to be easily carried, and is difficult to access for people with IBS [59]. Several psychological interventions have shown therapeutic usefulness in IBS regarding the relationship between psychological abnormalities and gastrointestinal symptoms. Web-based dietary monitoring [60], mindfulness [61], and cognitive behavioral therapy [62] have improved patients’ QOL and reduced their psychological distress [63]. Thus, support tools that are easily accessible to patients are being more widely used. In the present study, we generated a classifier based on the strength of functional connectivity in the DMN, which is characteristic of symptomatic young adults with IBS. This will be the basis for implementing the classifier in practical DecNef. We expect that a new EEG-DecNef device will be developed that analyzes the EEGs of patients with IBS, approximates the DMN characteristic of IBS symptoms, and feeds back the results to the patients.

This study has several limitations. First, the participants were young, and we did not conduct a stratified analysis by age. However, EEG results are known to vary with age [64], and nervous connectivity in brain networks is known to decrease with age [65]. In addition, IBS symptoms differ between younger and older adults [9]. Thus, considering the unique brain functions associated with aging can allow more accurate assessment and diagnosis of brain–gut interactions. Sex differences in IBS symptoms with constipation and diarrhea have also been reported [66]. Moreover, there are sex differences in the brain structure and abdominal organs of humans. Therefore, it is advisable to create and verify a classifier using age group and sex as determinants. Second, the participants in this study had mild IBS symptoms, and we did not conduct an analysis stratified by disease severity. EEG has been used as a biomarker of depressive symptoms [67], and has been proposed as a predictive tool based on the constant changes caused by treatment with selective serotonin reuptake inhibitors [68]. These results indicate that the EEG results change with mental and physical burdens. EEG analysis according to the severity of IBS can extend the means of support in patients with IBS, such as by reducing disease severity from severe to moderate and from moderate to mild. Third, the number of participants in this study was insufficient to provide a generalization of the model. The gut–brain axis is affected by eating behavior and food intake [56]; thus, a prospective study is recommended to implement a classifier that discriminates IBS symptoms adjusting for food contents and eating behavior. Fourth, the participants were not evaluated with diagnostic procedures, such as laboratory examinations or colonoscopy. Therefore, some of the participants could have had an organic cause for their digestive symptoms. However, identification of individuals with IBS in this study was based on the reliable IBS detection previously described [8]. We believe that our inclusion of a checklist of organic diagnoses that might account for GI symptoms and exclusion of such cases from the IBS diagnosis compensated at least partially for this possible selection bias. Finally, the IBS sample in our study did not show any complex symptoms associated with IBS, which limits the generality of the results. In IBS patients with chronic recurrent abdominal pain, pain is generally determined using the following factors: diet [69], intestinal environment [70], psychological state [71], and physical activity [72]. We did not investigate these factors in the present study. To understand the DMN and its complex symptoms characteristic of IBS, a cohort-based study investigating its relationship with EEG is needed. The results of these investigations will help generate classifiers for each subtype of abdominal pain, which will form the basis for IBS diagnosis and intervention protocols.

5. Conclusions

In this study, we generated a support vector machine classifier for discriminating IBS symptoms using the EEG power spectra in young adults with mild IBS. We also confirmed the high discriminative ability and accuracy of this classifier. This method of discrimination can help improve our ability to identify young adults with IBS symptoms using EEG data, and may be used as an evaluation index for self-control training.

Abbreviations

IBS, irritable bowel syndrome; QOL, quality of life; DMN, default mode network; RSFC, resting state functional connectivity; EEG, electroencephalography; DecNef, decoded neural feedback; fMRI, functional magnetic resonance imaging; EHI, Edinburgh Handedness Inventory; FFT, fast Fourier transform; SVM, support vector machine; AR, accuracy rate; TP, true positive; TN, true negative; N, sum of true positive, true negative, false positive, and false negative.

Author Contributions

Conceptualization and design—TH, JT, and SF; acquisition of data—KK, JT and TH; analysis and interpretation of data—KK, JT and TH; drafting of the manuscript—KK; critical revision—TH, SF. All authors have read and agreed to the published version of the manuscript.

Ethics Approval and Consent to Participate

This study was approved by the Review Boards of Saitama Prefectural University (#24075) and Nagasaki University (#13072632). Written consent was obtained from all participants.

Acknowledgment

We would like to thank the students of Saitama Prefectural University and Nagasaki University for their cooperation in this study.

Funding

This research was funded by the Japan Society for the Promotion of Science through grants (projects 19K11368 and 18KK0275). The staff at Saitama Prefectural University and Nagasaki University supported this research through participant recruitment and material procurement.

Conflict of Interest

All authors declare no conflicts of interest.

References
[1]
Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. The American Journal of Gastroenterology. 2018; 113: 1540–1549.
[2]
Yamamoto R, Kaneita Y, Osaki Y, Kanda H, Suzuki K, Higuchi S, et al. Irritable bowel syndrome among Japanese adolescents: a nationally representative survey. Journal of Gastroenterology and Hepatology. 2015; 30: 1354–1360.
[3]
Bonfiglio F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, Bujanda L, Bresso F, et al. Female-Specific Association between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology. 2018; 155: 168–179.
[4]
Goodoory VC, Houghton LA, Black CJ, Ford AC. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterology & Motility. 2022; 34: e14268.
[5]
Jamali R, Jamali A, Poorrahnama M, Omidi A, Jamali B, Moslemi N, et al. Evaluation of health related quality of life in irritable bowel syndrome patients. Health and Quality of Life Outcomes. 2012; 10: 12.
[6]
Addante R, Naliboff B, Shih W, Presson AP, Tillisch K, Mayer EA, et al. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared with Healthy Individuals. Journal of Clinical Gastroenterology. 2019; 53: e142–e149.
[7]
Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. New England Journal of Medicine. 2017; 376: 2566–2578.
[8]
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021; 160: 99–114.e3.
[9]
Kosako M, Akiho H, Miwa H, Kanazawa M, Fukudo S. Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey. BioPsychoSocial Medicine. 2018; 12: 12.
[10]
Kubo M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, et al. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterology & Motility. 2011; 23: 249–254.
[11]
Aasbrenn M, Høgestøl I, Eribe I, Kristinsson J, Lydersen S, Mala T, et al. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study. BMC Obesity. 2017; 4: 22.
[12]
Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive Self-Management for Irritable Bowel Syndrome. American Journal of Gastroenterology. 2009; 104: 3004–3014.
[13]
Black CJ, Ford AC. Best management of irritable bowel syndrome. Frontline Gastroenterology. 2020; 12: 303–315.
[14]
Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S. American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel Syndrome. Gastroenterology. 2014; 147: 1146–1148.
[15]
Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021; 116: 17–44.
[16]
Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. Journal of Gastroenterology. 2015; 50: 11–30.
[17]
Naliboff BD, Fresé MP, Rapgay L. Mind/Body Psychological Treatments for Irritable Bowel Syndrome. Evidence-Based Complementary and Alternative Medicine. 2008; 5: 41–50.
[18]
Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 2014; 109: 1350–1365.
[19]
Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000; 118: 842–848.
[20]
Tayama J, Saigo T, Ogawa S, Takeoka A, Hamaguchi T, Inoue K, et al. Effect of attention bias modification on event‐related potentials in patients with irritable bowel syndrome: a preliminary brain function and psycho‐behavioral study. Neurogastroenterology & Motility. 2018; 30: e13402.
[21]
Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, et al. Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002; 122: 1771–1777.
[22]
Killingsworth MA, Gilbert DT. A Wandering Mind is an Unhappy Mind. Science. 2010; 330: 932–932.
[23]
Nishijima S, Yada T, Yamazaki T, Kuroiwa Y, Nakane M, Fujino K, et al. Discrimination between Dementia Groups and Healthy Elderlies Using Scalp-Recorded-EEG-Based Brain Functional Connectivity Networks. Journal of Biomedical Science and Engineering. 2020; 13: 153–167.
[24]
Wager TD, Atlas LY. How is Pain Influenced by Cognition? Neuroimaging Weighs in. Perspectives on Psychological Science. 2013; 8: 91–97.
[25]
Kilpatrick LA, Mayer EA, Labus JS, Gupta A, Hamaguchi T, Mizuno T, et al. Serotonin transporter gene polymorphism modulates activity and connectivity within an emotional arousal network of healthy men during an aversive visceral stimulus. PLoS ONE. 2015; 10: e0123183.
[26]
Gao Z, Zhang D, Liang A, Liang B, Wang Z, Cai Y, et al. Exploring the Associations between Intrinsic Brain Connectivity and Creative Ability Using Functional Connectivity Strength and Connectome Analysis. Brain Connectivity. 2017; 7: 590–601.
[27]
Smallwood J, O’Connor RC. Imprisoned by the past: Unhappy moods lead to a retrospective bias to mind wandering. Cognition & Emotion. 2011; 25: 1481–1490.
[28]
Beach PA, Huck JT, Zhu DC, Bozoki AC. Altered behavioral and autonomic pain responses in Alzheimer’s disease are associated with dysfunctional affective, self-reflective and salience network resting-state connectivity. Frontiers in Aging Neuroscience. 2017; 9: 297.
[29]
Tolin DF, Davies CD, Moskow DM, Hofmann SG. Biofeedback and Neurofeedback for Anxiety Disorders: a Quantitative and Qualitative Systematic Review. Advances in Experimental Medicine and Biology. 2020; 4: 265–289.
[30]
Jiménez Morgan S, Molina Mora JA. Effect of Heart Rate Variability Biofeedback on Sport Performance, a Systematic Review. Applied Psychophysiology and Biofeedback. 2017; 42: 235–245.
[31]
Stanton R, Ada L, Dean CM, Preston E. Biofeedback improves performance in lower limb activities more than usual therapy in people following stroke: a systematic review. Journal of Physiotherapy. 2017; 63: 11–16.
[32]
Yu B, Funk M, Hu J, Wang Q, Feijs L. Biofeedback for everyday stress management: a systematic review. Frontiers in ICT. 2018; 5.
[33]
Shibata K, Watanabe T, Sasaki Y, Kawato M. Perceptual Learning Incepted by Decoded fMRI Neurofeedback without Stimulus Presentation. Science. 2011; 334: 1413–1415.
[34]
Oblak EF, Sulzer JS, Lewis-Peacock JA. A simulation-based approach to improve decoded neurofeedback performance. NeuroImage. 2019; 195: 300–310.
[35]
Ge Y, Pan Y, Wu Q, Dou W. A distance-based neurorehabilitation evaluation method using linear SVM and resting-state fMRI. Frontiers in Neurology. 2019; 10: 1105.
[36]
Shahparian N, Yazdi M, Khosravi MR. Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM). Current Signal Transduction Therapy. 2021; 16: 171–177.
[37]
Chisci L, Mavino A, Perferi G, Sciandrone M, Anile C, Colicchio G, et al. Real-Time Epileptic Seizure Prediction Using AR Models and Support Vector Machines. IEEE Transactions on Biomedical Engineering. 2010; 57: 1124–1132.
[38]
Mao CP, Chen FR, Huo JH, Zhang L, Zhang GR, Zhang B, et al. Altered resting‐state functional connectivity and effective connectivity of the habenula in irritable bowel syndrome: a cross‐sectional and machine learning study. Human Brain Mapping. 2020; 41: 3655–3666.
[39]
Chen Z, Lu G, Xie Z, Shang W. A Unified Framework and Method for EEG-Based Early Epileptic Seizure Detection and Epilepsy Diagnosis. IEEE Access. 2020; 8: 20080–20092.
[40]
Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology. 2016; 150: 1393–1407.e5.
[41]
Takabatake K, Kunii N, Nakatomi H, Shimada S, Yanai K, Takasago M, et al. Musical Auditory Alpha Wave Neurofeedback: Validation and Cognitive Perspectives. Applied Psychophysiology and Biofeedback. 2021; 46: 323–334.
[42]
Yeo MVM, Li X, Shen K, Wilder-Smith EPV. Can SVM be used for automatic EEG detection of drowsiness during car driving? Safety Science. 2009; 47: 115–124.
[43]
Han J, Pei J, Kamber M. Data mining: concepts and techniques. Elsevier: San Francisco, CA. 2012.
[44]
Bishop DVM, Ross VA, Daniels MS, Bright P. The measurement of hand preference: a validation study comparing three groups of right-handers. British Journal of Psychology. 1996; 87: 269–285.
[45]
Kaneno T, Sato A, Akizuki K, Yamaguchi A, Yasaki K, Morita Y. Assessing the adjustability of grasping force using the iWakka in elderly individuals. Journal of Physical Therapy Science. 2017; 29: 2215–2219.
[46]
Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-Gut Response to Stress and Cholinergic Stimulation in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 1993; 17: 133–141.
[47]
Nomura T, Fukudo S, Matsuoka H, Hongo M. Abnormal electroencephalogram in irritable bowel syndrome. Scandinavian Journal of Gastroenterology. 1999; 34: 478–484.
[48]
Neshov NN, Manolova AH, Draganov IR, Tonschev KT, Boumbarov OL. Classification of Mental Tasks from EEG Signals Using Spectral Analysis, PCA and SVM. Cybernetics and Information Technologies. 2018; 18: 81–92.
[49]
Takamiya A, Hirano J, Yamagata B, Takei S, Kishimoto T, Mimura M. Electroconvulsive therapy modulates resting-state EEG oscillatory pattern and phase synchronization in nodes of the default mode network in patients with depressive disorder. Frontiers in Human Neuroscience. 2019; 13: 1.
[50]
Saigo T, Tayama J, Hamaguchi T, Nakaya N, Tomiie T, Bernick PJ, et al. Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students. BioPsychoSocial Medicine. 2014; 8: 10.
[51]
Shon D, Im K, Park JH, Lim DS, Jang B, Kim JM. Emotional stress state detection using genetic algorithm-based feature selection on EEG signals. International Journal of Environmental Research and Public Health. 2018; 15: 2461.
[52]
Fukudo S, Kanazawa M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. Journal of Gastroenterology and Hepatology. 2011; 26: 110–115.
[53]
Ezra M, Faull OK, Jbabdi S, Pattinson KT. Connectivity-based segmentation of the periaqueductal gray matter in human with brainstem optimized diffusion MRI. Human Brain Mapping. 2015; 36: 3459–3471.
[54]
Lu C, Yang T, Zhao H, Zhang M, Meng F, Fu H, et al. Insular Cortex is Critical for the Perception, Modulation, and Chronification of Pain. Neuroscience Bulletin. 2016; 32: 191–201.
[55]
Hamaguchi T, Kano M, Kanazawa M, Itoh M, Yanai K, Fukudo S. Effects of Preceding Stimulation on Brain Activation in Response to Colonic Distention in Humans. Psychosomatic Medicine. 2013; 75: 453–462.
[56]
Wu J, Masuy I, Biesiekierski JR, Fitzke HE, Parikh C, Schofield L, et al. Gut‐brain axis dysfunction underlies FODMAP‐induced symptom generation in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2022; 55: 670–682.
[57]
Chiba T, Kanazawa T, Koizumi A, Ide K, Taschereau-Dumouchel V, Boku S, et al. Current status of neurofeedback for post-traumatic stress disorder: a systematic review and the possibility of decoded neurofeedback. Frontiers in Human Neuroscience. 2019; 13: 233.
[58]
Fede SJ, Dean SF, Manuweera T, Momenan R. A guide to literature informed decisions in the design of real time fMRI neurofeedback studies: a systematic review. Frontiers in Human Neuroscience. 2020; 14: 60.
[59]
Tursic A, Eck J, Lührs M, Linden DEJ, Goebel R. A systematic review of fMRI neurofeedback reporting and effects in clinical populations. NeuroImage: Clinical. 2020; 28: 102496.
[60]
Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J. Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 2017; 32: 27–31.
[61]
Mikolasek M, Berg J, Witt CM, Barth J. Effectiveness of Mindfulness- and Relaxation-Based eHealth Interventions for Patients with Medical Conditions: a Systematic Review and Synthesis. International Journal of Behavioral Medicine. 2018; 25: 1–16.
[62]
Hunt MG. Cognitive-Behavioral Therapy for Irritable Bowel Syndrome. Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction. 2019; 130: 95–141.
[63]
Rohde JA, Barker JO, Noar SM. Impact of eHealth technologies on patient outcomes: a meta-analysis of chronic gastrointestinal illness interventions. Translational Behavioral Medicine. 2021; 11: 1–10.
[64]
Tomescu MI, Rihs TA, Rochas V, Hardmeier M, Britz J, Allali G, et al. From swing to cane: Sex differences of EEG resting-state temporal patterns during maturation and aging. Developmental Cognitive Neuroscience. 2018; 31: 58–66.
[65]
Chan MY, Park DC, Savalia NK, Petersen SE, Wig GS. Decreased segregation of brain systems across the healthy adult lifespan. Proceedings of the National Academy of Sciences. 2014; 111: E4997–E5006.
[66]
Katsumata R, Shiotani A, Murao T, Ishii M, Fujita M, Matsumoto H, et al. Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome. Internal Medicine. 2017; 56: 993–999.
[67]
Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Molecular Psychiatry. 2020; 25: 321–338.
[68]
Ip C, Ganz M, Dam VH, Ozenne B, Rüesch A, Köhler-Forsberg K, et al. NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD. Journal of Psychiatric Research. 2021; 141: 57–65.
[69]
Krieger-Grübel C, Hutter S, Hiestand M, Brenner I, Güsewell S, Borovicka J. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: a randomized, cross-over designed study. Clinical Nutrition ESPEN. 2020; 40: 83–89.
[70]
Vermeulen W. Neuroanatomy of lower gastrointestinal pain disorders. World Journal of Gastroenterology. 2014; 20: 1005.
[71]
Simrén M, Törnblom H, Palsson OS, van Tilburg MAL, Van Oudenhove L, Tack J, et al. Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut. 2018; 67: 255–262.
[72]
Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical Activity Improves Symptoms in Irritable Bowel Syndrome: a Randomized Controlled Trial. American Journal of Gastroenterology. 2011; 106: 915–922.
Share
Back to top